Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alembic Charts China Plans, Sees Price Cuts As No Dampener

Executive Summary

Alembic has firmed up a joint venture to tap into emerging opportunities in China amid evolving regulations there, and believes the market holds significant promise despite rising price pressures.

Advertisement

Related Content

China Releases List To Encourage Competition
Bring Them On: China Releases Generics List To Encourage Competition
China Beckons: Sun Joins Indian Firms Priming For Larger Presence
Drug Price Waterloo: China's New Bidding Process Hits MNCs Hard
Cancer, Orphan, Pediatric Drug Developers Join China Foreign Data Acceptance Party

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC125195

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel